Rubenstein JH, Inadomi JM. Potential for Lead-Time and Length-Time Biases in Outcomes in Esophageal Adenocarcinoma. American Journal Of Gastroenterology. 2009;104:3106-3107.
Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM. American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008 (vol 104 pg 739 2009). American Journal Of Gastroenterology. 2009;104:1612-1612.
Inadomi JM, Somsouk MA, Madanick RD, Thomas JP, Shaheen NJ. A Cost-Utility Analysis of Ablative Therapy for Barrett's Esophagus. Gastroenterology. 2009;136:2101-2114.
Inadomi JM, Gunnarsson CL, Rizzo JA, Fang H, Ye X. Projected Growth Rate of Anesthesiologist-Delivered Sedation in Colonoscopy and EGD in the United States: 2009-2011. Gastrointestinal Endoscopy. 2009;69:Suppl.SAB111.
Sorrell MF, Belongia EA, Costa J, Gareen IF, Grem JL, Inadomi JM, Kern ER, McHugh JA, Petersen GM, Rein MF, Strader DB, Trotter HT. National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis B. Annals Of Internal Medicine. 2009;150:104-U63.
Rubenstein JH, Dahlkemper A, Kao JY, Zhang M, Morgenstern H, McMahon L, Inadomi JM. A pilot study of the association of low plasma adiponectin and Barrett's esophagus. American Journal Of Gastroenterology. 2008;103:1358-1364.
Vijan S, Hwang I, Inadomi J, Wong RKH, Choi JR, Napierkowski J, Koff JM, Pickhardt PJ. The cost-effectiveness of CT colonography in screening for colorectal neoplasia. American Journal Of Gastroenterology. 2007;102:380-390.
Rubenstein JH, Vakil N, Inadomi JM. The cost-effectiveness of biomarkers for predicting the development of oesophageal adenocarcinoma. Alimentary Pharmacology & Therapeutics. 2005;22:135-146.
Shaheen NJ, Inadomi JM, Overholt BF, Sharma P. What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis. Gut. 2004;53:1736-1744.
Inadomi JM, Sampliner R, Lagergren J, Lieberman D, Fendrick AM, Vakil N. Screening and surveillance for Barrett esophagus in high-risk groups: A cost-utility analysis. Annals Of Internal Medicine. 2003;138:176-186.
Cram PM, Vijan S, Inadomi JM, Cowen ME, Carpenter D, Fendrick AM. The impact of a celebrity spokesperson on preventive health behavior: The Katie Couric effect. Journal Of General Internal Medicine. 2002;17:Suppl.1188-188.
Inadomi JM, Jamal R, Murata GH, Hoffman RM, Lavezo LA, Vigil JM, Swanson KM, Sonnenberg A. Step-down management of gastroesophageal reflux disease. Gastroenterology. 2001;121:1095-1100.
Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Annals Of Internal Medicine. 2000;133:573-584.
Inadomi JM, Sonnenberg A. The impact of colorectal cancer screening on life expectancy. Gastrointestinal Endoscopy. 2000;51:517-523.
El-Serag HB, Inadomi JM, Kowdley KV. Screening for hereditary hemochromatosis in siblings and children of affected patients - A cost-effectiveness analysis. Annals Of Internal Medicine. 2000;132:261.